Executive Editor, Regulatory and Policy Insights, U.S.
Citeline - The Pink Sheet
Derrick focuses on the US FDA user fee programs, regulations and policy for new and generic drugs, biologics and biosimilars, advisory committee and other agency activities, as well as federal legislation and budget matters on Capitol Hill. He also hosts Drug Fix, the Pink Sheet's Pharma Regulatory Podcast. An award-winning journalist, Derrick has been a reporter for several community newspapers and a business journal. When not following FDA, Derrick is keeping close tabs on Indiana University basketball.
FDA Forecast: What the FDA has Planned in 2026 for Pharmaceuticals and Biotechnology Products
Wednesday, October 8, 2025
2:15 PM - 3:15 PM EST